Two retrospective observational studies involving children and adults with CF and ABPA showed that a combination of oral corticosteroids and voriconazole led to a reduction in oral corticosteroid doses required, as well as a reduction in total IgE and improved FEV1 [171,172]. The gene discussed is IGHE; the disease is cystic fibrosis.